NCT05410145 2026-03-12A Study of D3S-001 Monotherapy or Combination Therapy in Subjects With Advanced Solid Tumors With a KRAS p.G12C MutationD3 Bio (Wuxi) Co., LtdPhase 1/2 Recruiting442 enrolled